IV steroids during long episodes of Kleine-Levin syndrome.

Détails

ID Serval
serval:BIB_4C7E083B9ED1
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
IV steroids during long episodes of Kleine-Levin syndrome.
Périodique
Neurology
Auteur(s)
Léotard A., Groos E., Chaumereuil C., Peter-Derex L., Rossetti A.O., Leu-Semenescu S., Arnulf I.
ISSN
1526-632X (Electronic)
ISSN-L
0028-3878
Statut éditorial
Publié
Date de publication
24/04/2018
Peer-reviewed
Oui
Volume
90
Numéro
17
Pages
e1488-e1492
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
To retrospectively compare the benefits (episode cessation) and risks of IV methylprednisolone (IV-MP) vs abstention during prolonged Kleine-Levin syndrome (KLS) episodes.
A total of 26 patients with KLS received 1 g/d IV-MP for 3 days during 1 to 6 episodes each (totaling 43 IV-MP sessions). The change of episode duration with IV-MP (vs previous episode duration) was compared with the change duration between 2 consecutive episodes in 48 untreated patients matched for age, sex, age at KLS onset, number of episodes, and disease duration (more treated than untreated patients had long episodes).
Eleven patients (42.3%) had an episode that was at least 1 week shorter than the preceding one when they received IV-MP therapy, whereas shorter episodes were significantly less frequent (10.4%) in the untreated group. This benefit was more marked (65.5% responders, 12 fewer days in an episode vs 0 days in the untreated patients) when IV-MP was infused before the 10th day of the episode. Mild, transient adverse effects (insomnia, muscle pain, nervousness/restlessness, but no manic switching) were reported by 61.3% of patients. No specific responder profile was identified.
In this open-labeled, naturalistic study, early IV-MP (following the protocol for multiple sclerosis relapses) had a good benefit/risk ratio during KLS episodes in patients with long episodes (with half of the patients having an early cessation of episodes).
This study provides Class IV evidence that for patients with long episodes of KLS, IV steroids decrease the duration of KLS episodes.
Mots-clé
Administration, Intravenous, Adolescent, Adult, Female, Humans, Kleine-Levin Syndrome/diagnostic imaging, Kleine-Levin Syndrome/drug therapy, Male, Methylprednisolone/therapeutic use, Neuroprotective Agents/therapeutic use, Retrospective Studies, Treatment Outcome, Young Adult
Pubmed
Web of science
Création de la notice
29/03/2018 18:22
Dernière modification de la notice
20/08/2019 14:00
Données d'usage